跳转至内容
Merck
CN

W-003

Supelco

Warfarin solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价

选择尺寸

关于此项目

经验公式（希尔记法）:
C19H16O4
化学文摘社编号:
81-81-2
分子量:
308.33
UNSPSC代码:
41116107

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

certified reference material

表单

liquid

特点

Snap-N-Spike®/Snap-N-Shoot®

包装

ampule of 1 mL

制造商/商品名称

Cerilliant®

浓度

1.0 mg/mL in acetonitrile

技术

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

应用

clinical testing

包装形式

single component solution

储存温度

2-8°C

SMILES字符串

CC(=O)CC(C1C(=O)Oc2ccccc2C1=O)c3ccccc3

InChI

1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,17H,11H2,1H3

InChI key

FQEPJUOLUDFINX-UHFFFAOYSA-N

一般描述

Warfarin is an anticoagulant sold under the trade names Coumadin® and Jantoven®. Warfarin is also used a pesticide, most often as rat poison. This Snap-N-Spike® reference solution is applicable for use in clinical toxicology, forensic analysis, therapeutic drug monitoring or environmental monitoring and diagnostic testing applications by LC-MS/MS or GC/MS

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Coumadin is a registered trademark of Bristol-Myers Squibb Co.
Jantoven is a registered trademark of Upsher-Smith Laboratories, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2

靶器官

Blood

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

35.6 °F - closed cup

闪点(°C)

2 °C - closed cup

法规信息

危险化学品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Case 1: chronic thromboembolic pulmonary hypertension (CTEPH).
D T Murphy et al.
Irish medical journal, 106(5), 146-147 (2013-08-07)
Masatsugu Hori et al.
Stroke, 44(7), 1891-1896 (2013-06-08)
Intracranial hemorrhage rates are higher in Asians than non-Asians, especially in patients receiving warfarin. This randomized evaluation of long-term anticoagulation therapy subgroup analysis assessed dabigatran etexilate (DE) and warfarin effects on stroke and bleeding rates in patients from Asian and
Ask the doctors. I have atrial fibrillation and have been taking warfarin to prevent blood clots for 10 years. It has not given me any problems. However, I do hate going to my doctor's office to get my INR blood test every month. I'm wondering whether I should switch to one of the newer blood thinners that don't require blood testing.
Thomas Lee et al.
Harvard heart letter : from Harvard Medical School, 23(5), 2-2 (2013-07-12)
Miroslav Tomić et al.
Collegium antropologicum, 37(2), 629-632 (2013-08-15)
We are presenting a rare case of a spontaneous extensive perirenal hematoma caused by ruptured renal adenocarcinoma in a patient who was on warfarin therapy because she had atrial fibrillation and three myocardial infarctions. A 77-year-old woman was admitted to
[Vascular calcification: a common but overlooked condition].
Peter Stenvinkel
Lakartidningen, 110(21), 1041-1044 (2013-06-29)
查看所有相关文献

商品

Protein Binding Determination - Comparison Study of Techniques & Devices

Comparative analysis of Supel™ BioSPME 96-Pin device with a rapid equilibrium dialysis technique for accuracy of measured values, sample cleanliness, and workflow time in drug protein binding.

实验方案

HPLC Analysis of Warfarin Anticoagulant on Ascentis C18

HPLC Analysis of Warfarin™ Anticoagulant on Ascentis® C18

Chiral and Achiral LC-MS Analysis of Warfarin™ in Plasma Samples

This study demonstrates the analysis of Warfarin in plasma samples utilizing chiral and achiral (reversed-phase) LC-MS and effective sample prep to remove endogenous phospholipids

Chromatograms

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持